BRP amends and extends its term facility
Post ContentRead More
Peoples Bancorp of North Carolina GAAP EPS of $0.62, revenue of $19.39M
Post ContentRead More
Gilead in selloff after late-stage setback for Trodelvy
Post ContentRead More
Southern States Bancshares Non-GAAP EPS of $0.81, revenue of $23.53M
Post ContentRead More
Initial demand for Apple’s Vision Pro headset could wane, top analyst cautions
Apple’s Vision Pro quickly sold out after preorders opened Friday, but early signs could mean demand is waning, a top Apple analyst wrote.
Why China poses a growing threat to the U.S. auto industry
Chinese companies are releasing new models in record times, and many are producing EVs efficiently and profitably.
Stocks making the biggest moves midday: Vita Coco, Archer-Daniels-Midland, Gilead Sciences and more
These are the stocks posting the largest moves in midday trading.
Gilead stock falls after lung cancer study results disappoint
Gilead will discuss the results with regulators and identify whether certain lung cancer patients may still benefit from the drug, known as Trodelvy.
Meta’s retreat from news accelerated in 2023, leaving publishers scrambling for traffic
Meta has been de-emphasizing news across Facebook’s feed, upending many publishers that had come to rely on referral traffic.
Top analyst Mike Mayo turns bullish on Citigroup with Warren Buffett as an influential investor
Bank analyst Mike Mayo named Citigroup his top pick, saying that he realized the embattled bank is under the influence of none other than Warren Buffett.
